Biomarkers for predicting efficacy of chimeric antigen receptor T cell therapy and their detection methods
Bo Zou(Jilin University), Qibin Liao(Southern University of Science and Technology), Yuanzheng Peng(Southern University of Science and Technology), Yuzi Zhang(BASIS International (United States)), Wanshan Wei(Southern University of Science and Technology), Ning Li(Shenyang Pharmaceutical University), Jie Li(Southern University of Science and Technology), Hongzhou Lu(Southern University of Science and Technology), Xianmin Meng(Peking Union Medical College Hospital), Zhongyi Fan(Wenzhou University), Xiaohua Tan(Hangzhou Normal University), Yinan Su(Southern University of Science and Technology), Yan-Zhou Song(Southern University of Science and Technology)
Cited by 3
Related Papers
Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis
|Journal of Clinical Investigation|2013|249
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China
|JAMA Internal Medicine|2020|240
PLAG1 fusion oncogenes in lipoblastoma.
|PubMed|2000|234
Dynamic Behavior of Molecular Switches in Crystal under Pressure and Its Reflection on Tactile Sensing
|Journal of the American Chemical Society|2014|220